Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 4, 2001, Pages 557-561

  Fuchs, P C ^a   Barry, A L ^a   Brown, S D ^a  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DAPTOMYCIN; LIPOPEPTIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; DRUG SCREENING; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; MONITORING; NONHUMAN; QUALITY CONTROL; SPECIES;

EID: 0034765359     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/48.4.557     Document Type: Article

References (10)

1. Susceptibility of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to new antimicrobial agents, including daptomycin, teicoplanin, cefpodoxime and quinolones
2. In vitro and in vivo activity of LY146032, a new cyclic lipopeptide antibiotic
3. Antimicrobial activity and spectrum of LY146032, a lipopeptide antibiotic, including susceptibility test recommendations
4. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility test recommendations
5. Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species
6. Daptomycin: A novel agent for Gram-positive infections
7. Daptomycin susceptibility tests: Interpretive criteria, quality control, and effect of calcium on in vitro tests
8. Effects of reduced cation supplement recommendations (National Committee for Clinical Laboratory Standards) on daptomycin antistaphylococcal activity